LOS ANGELES -- The novel agent soticlestat flopped in a pair of phase III trials for rare seizure disorders, researchers reported here. Among Dravet syndrome patients in the SKYLINE trial ...

The approach has had phenomenal success, with King’s laboratory uncovering possible therapies for Dravet syndrome, epilepsy, abdominal pain, and stroke. Dravet syndrome is a rare and life ...

Takeda’s experimental epilepsy drug soticlestat has failed not one but two phase 3 trials – in Dravet syndrome and Lennox-Gastaut syndrome – throwing the future of the programme in doubt.

Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show. The BECOME-TSC study evaluated outcomes of Epidiolex (Jazz ...

LOS ANGELES — A wearable, behind-the-ear EEG device is feasible for assessment of sleep patterns in young people with Dravet syndrome, according to a poster presented at the American Epilepsy ...

Daily seizures make it unsafe for her to be left ... of raising children with rare conditions. "My daughter has Dravet syndrome, she's 3, and I'm not sure what kind of life she will have.

Praxis Precision Medicines, Inc. has announced that the U.S. FDA has granted Rare Pediatric Disease Designation for its drug relutrigine in treating Dravet syndrome, a severe genetic epilepsy ...

Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial designed to prove that its experimental drug for Dravet syndrome, a severe form of epilepsy, can both reduce ...

Pirates from across the country attended the funeral of a 14-year-old fan of all things swashbuckling. Billy Maskell, from ...

The medicine will be used to treat two rare, but severe, forms of childhood epilepsy - Lennox Gastaut syndrome and Dravet syndrome - which can cause multiple seizures a day. Epilepsy Action's ...

Massachusett-based Stoke Therapeutics STOK is making rapid progress with the development of zorevunersen (STK-001), its ...